Back to Authors

Hirano, Yudai

https://orcid.org/0000-0003-4043-0593

Mayo Clinic

University of Tokyo Hospital

Citations 1

Effectiveness and Safety of Hypofractionated Gamma Knife Radiosurgery for Large Meningiomas and Those Adjacent to the Optic Pathway and Brainstem: Preliminary Therapeutic Outcomes
Hirano, Yudai , Shinya, Yuki , Umekawa, Motoyuki , Kawashima, Mariko , Wipplinger, Tamara , Shinya, Yuki , Hasegawa, Hirotaka , Wipplinger, Christoph , Katano, Atsuto , Saito, Nobuhito

No container title available | November 27, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-5147270/v1 Get It

Abstract Background Recent technologic advancements have facilitated the use of hypofractionated Gamma Knife-based radiosurgery (HF-GKRS) to treat large lesions or those in eloquent areas. This study aimed to analyze the preliminary results of HF-GKRS for these meningiomas, and to determine its effectiveness and safety. Methods This single-center retrospective study analyzed data of patients who underwent HF-GKRS for large meningiomas or those in eloquent areas with > 6 months of follow-up. The primary outcome was progression-free survival (PFS). The secondary outcomes were neurological deterioration, post-treatment T2 signal changes following HF-GKRS, and tumor volume changes. Volumetric analysis of the tumors after treatment was also performed to assess changes in tumor size after HF-GKRS. Results Overall, 24 patients with a median follow-up period of 22 months (range: 6–49 months) were included. Among them, 18 (75%) patients had tumors in close proximity to the optic pathway, and 15 (63%) patients had large lesions (> 10 cm3). The cumulative 1- and 3-year PFS rates were 100% and 92%, respectively. The cumulative 3-year rate of adverse radiation effects was 9%. Overall, 12 patients (50%) showed tumor reduction, with a median tumor reduction rate of 45% (range: 25–58%). Conclusions Our preliminary results revealed that HF-GKRS for large meningiomas or those in eloquent areas is safe and effective, with satisfactory short- and mid-term PFS and low adverse radiation effects. Further research with more patients and longer follow-up periods is required.